Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer
International Journal of Molecular Sciences · 10.06.2023 · 24 (12) · 9984
DOI: 10.3390/ijms24129984 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.06.2023. Verfasst von Luis M Ruiz-Manriquez und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health Sciences, Tecnologico de Monterrey, Monterrey 64700, Mexico. Hauptthemen laut MEDLINE: Breast Neoplasms, Circulating MicroRNA, MicroRNAs. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer (BC) is a leading cause of cancer-related deaths among women worldwide. Neoadjuvant therapy (NAT) is increasingly being used to reduce tumor burden prior to surgical resection. However, current techniques for assessing tumor response have significant limitations. Additionally, drug resistance is commonly observed, raising a need to identify biomarkers that can predict treatment sensitivity and survival outcomes. Circulating microRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and have been shown to play a significant role in cancer progression as tumor inducers or suppressors. The expression of circulating miRNAs has been found to be significantly altered in breast cancer patients. Moreover, recent studies have suggested that circulating miRNAs can serve as non-invasive biomarkers for predicting response to NAT. Therefore, this review provides a brief overview of recent studies that have demonstrated the potential of circulating miRNAs as biomarkers for predicting the clinical response to NAT in BC patients. The findings of this review will strengthen future research on developing miRNA-based biomarkers and their translation into medical practice, which could significantly improve the clinical management of BC patients undergoing NAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Health Sciences, Tecnologico de Monterrey, Monterrey 64700, Mexico.
- School of Engineering and Sciences, Tecnologico de Monterrey, Queretaro 76130, Mexico.
- Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Monterrey 64700, Mexico.
ORCID-Profile: Andrea Torres-Copado, Carolina Estrada-Meza, Sujay Paul
Zitieren
APA
Ruiz-Manriquez, L. M., Villarreal-Garza, C., Benavides-Aguilar, J. A., Torres-Copado, A., Isidoro-Sánchez, J., Estrada-Meza, C., Arvizu-Espinosa, M. G., Paul, S., & Cuevas-Diaz Duran, R. (2023). Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer. International Journal of Molecular Sciences, 24(12), 9984. https://doi.org/10.3390/ijms24129984
Vancouver
Ruiz-Manriquez LM, Villarreal-Garza C, Benavides-Aguilar JA, Torres-Copado A, Isidoro-Sánchez J, Estrada-Meza C, et al. Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer. International Journal of Molecular Sciences. 2023;24(12):9984. doi:10.3390/ijms24129984
BibTeX
@article{RuizManriquez2023,
author = {Ruiz-Manriquez, Luis M and Villarreal-Garza, Cynthia and Benavides-Aguilar, Javier A and Torres-Copado, Andrea and Isidoro-Sánchez, José and Estrada-Meza, Carolina and Arvizu-Espinosa, María Goretti and Paul, Sujay and Cuevas-Diaz Duran, Raquel},
title = {Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {12},
pages = {9984},
doi = {10.3390/ijms24129984}
}
EUVIMED